APA (7th ed.) Citation

K, B., S, C., A, A., L, A., SA, J., I, R., . . . K, P. (2021). Sensitive Blood-Based Detection of Asbestos-Associated Diseases Using Cysteine-Rich Angiogenic Inducer 61 as Circulating Protein Biomarker. Clinical chemistry, 67(2), 363. https://doi.org/10.1093/clinchem/hvaa232

Chicago Style (17th ed.) Citation

K, Bartkowiak, et al. "Sensitive Blood-Based Detection of Asbestos-Associated Diseases Using Cysteine-Rich Angiogenic Inducer 61 as Circulating Protein Biomarker." Clinical Chemistry 67, no. 2 (2021): 363. https://doi.org/10.1093/clinchem/hvaa232.

MLA (9th ed.) Citation

K, Bartkowiak, et al. "Sensitive Blood-Based Detection of Asbestos-Associated Diseases Using Cysteine-Rich Angiogenic Inducer 61 as Circulating Protein Biomarker." Clinical Chemistry, vol. 67, no. 2, 2021, p. 363, https://doi.org/10.1093/clinchem/hvaa232.